Paul-Ehrlich-Institut

Information on the Use of Cookies

In order to operate and optimise our website, we would like to collect and analyse statistical information completely anonymously. Will you accept the temporary use of statistics cookies?

You can revoke your consent at any time in our privacy policy.

OK

COVID 19 mRNA Vaccine Comirnaty – Shelf Life Extended

For BioNTech/Pfizer's Comirnaty vaccine, the shelf life for frozen vials was extended from six to nine months in the European Union on 10 September 2021. This three-month extension applies to vials of vaccine batches manufactured after the approval was granted. In addition, this three-month extension may also be applied retroactively to vials of batches manufactured before the approval was granted. The storage conditions of -90 °C to -60 °C remain unchanged.

COVID-19 Vaccine Corminaty (Source: JFCfilms/pixabay.de)

Extension of the shelf life by three months applies to all vials manufactured after 10.09.2021. In future, all vials with an expiry date after March 2022 will already have a nine-month shelf life and will be labelled accordingly.

For vials manufactured before 10 September 2021, it is possible to apply the shelf life extension of three months retroactively if the carton shows an expiry date printed on the label between June 2021 and March 2022 and the approved storage conditions between -90 °C and -60 °C have been observed.

For such batches of Comirnaty vaccine currently already in circulation, the following expiry dates will then apply:

Imprinted dateUpdated expiration date
June 2021September 2021
July 2021October 2021
August 2021November 2021
September 2021December 2021
October 2021January 2022
November 2021February 2022
December 2021March 2022
January 2022April 2022
February 2022May 2022
March 2022June 2022

The requirements for storage conditions from -90 °C to -60 °C remain unchanged. Within the nine-month shelf life, unopened vials can be stored and transported at 25 °C to 15 °C for a total of two weeks. Thereafter, storage at -90 °C to -60 °C is possible.

This COVID-19 vaccine is being marketed on the basis of the Regulation on the Provision of Medical Supplies to the Population in the Event of a Pandemic caused by the SARS-CoV-2 Coronavirus (Medizinischer Bedarf Versorgungssicherstellungsverordnung, MedBVSV).

The product information of Comirnaty has already been updated. All additional information from the manufacturer on Comirnaty affected by this change will be updated accordingly.

Further Information

Product Information: Comirnaty

Updated: 01.10.2021